The US FDA has approved scPharmaceuticals’ sNDA for Furoscix, expanding its indication to include oedema treatment…
Author: admin
FDA approves scPharmaceuticals’ Furoscix sNDA for oedema in CKD
The US FDA has approved scPharmaceuticals’ sNDA for Furoscix, expanding its indication to include oedema treatment…
Pfizer appoints former J&J executive to lead obesity drug development – Reuters
Pfizer appoints former J&J executive to lead obesity drug development Reuters
Does ‘Oatzempic’ Help You Lose Weight? – Verywell Health
Does ‘Oatzempic’ Help You Lose Weight? Verywell Health
Industry Voices—The GLP-1 status quo is no longer acceptable, but it is changeable. – Fierce healthcare
Industry Voices—The GLP-1 status quo is no longer acceptable, but it is changeable. Fierce healthcare
The rise of the Ozempic menu and how weight-loss drugs are changing dining out – The Independent
The rise of the Ozempic menu and how weight-loss drugs are changing dining out The Independent
Weight loss drugs like Ozempic a boon for Streeterville plastic surgery clinic, boosting demand for facelifts – Chicago Sun-Times
Weight loss drugs like Ozempic a boon for Streeterville plastic surgery clinic, boosting demand for facelifts Chicago…
Is your weight loss drug affecting your relationship? – The Indian Express
Is your weight loss drug affecting your relationship? The Indian Express
The trillion-dollar opportunity in women’s health
Closing the gap in health interventions between men and women could add $1tn to the global…
FDA ODD given to Plus Therapeutics’ injectable radiotherapy
The FDA has granted orphan drug designation to Plus Therapeutics’ injectable radiotherapy, Rhenium (186Re) Obisbemeda.